Akers Biosciences Further Extends Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
03 juil. 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., July 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
29 juin 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Granted 180-Day Extension by Nasdaq to Meet Minimum Bid Price Requirement
30 mai 2018 18h09 HE
|
Akers Biosciences Inc
THOROFARE, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Announces a Change to the Board of Directors
29 mai 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
29 mai 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq
25 mai 2018 16h30 HE
|
Akers Biosciences Inc
THOROFARE, N.J., May 25, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces...
Akers Biosciences Expands Outsourced US Distribution Capabilities for Heparin PF4 Rapid Test
12 avr. 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Reports Earnings for Fiscal Year 2017
03 avr. 2018 07h03 HE
|
Akers Biosciences Inc
Total Revenue Up 33% THOROFARE, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers”, “Akers Bio” or the "Company"), a developer of rapid health...
Akers Biosciences Announces Rescheduled Conference Call to Discuss Fiscal Year 2017 Earnings
28 mars 2018 11h20 HE
|
Akers Biosciences Inc
THOROFARE, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...
Akers Biosciences Signs US Distribution Agreement with Diagnostica Stago
26 mars 2018 07h00 HE
|
Akers Biosciences Inc
THOROFARE, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, has...